Fluorotechnics' Q1 Revenues Drop to $224K | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian fluorescence and protein detection technologies firm Fluorotechnics last week reported revenues from customers for the first quarter of A$204,346 (US$224,006), down nearly nine-fold from A$1.8 million a year ago.

The company, which is in the middle of a turnaround effort, also reported net operating cash flows came in at a loss of A$273,609 for the three months ended March 31, compared to a loss of A$1.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.